Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China flag China · Delayed Price · Currency is CNY
26.56
-0.24 (-0.90%)
Apr 9, 2026, 3:00 PM CST

SHA:600196 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,10413,52413,69416,24110,317
Trading Asset Securities
2,2542,5961,888928.534,241
Cash & Short-Term Investments
15,35816,12015,58217,17014,558
Cash Growth
-4.73%3.45%-9.25%17.94%22.01%
Accounts Receivable
9,9558,7658,4578,1726,474
Other Receivables
712.79676.66636.27611.57875.26
Receivables
10,6689,4429,0938,7837,538
Inventory
6,2527,2597,5386,8825,473
Other Current Assets
1,5431,6711,5802,4432,868
Total Current Assets
33,82134,49133,79335,27930,437
Property, Plant & Equipment
24,08423,41122,23916,02813,284
Long-Term Investments
27,26925,86525,01225,54923,920
Goodwill
10,81010,90510,85210,3379,400
Other Intangible Assets
13,99914,46813,48212,47110,276
Long-Term Accounts Receivable
213.33198.8383.0191.6677.4
Long-Term Deferred Tax Assets
985.34757.78624.47442.57265.59
Long-Term Deferred Charges
7,5936,2504,6754,0083,632
Other Long-Term Assets
1,2801,1142,5122,8362,014
Total Assets
120,054117,461113,470107,16493,306
Accounts Payable
5,1445,9976,1606,2845,064
Accrued Expenses
5,6495,4085,4145,5774,807
Short-Term Debt
15,53018,71114,72811,93210,629
Current Portion of Long-Term Debt
5,6353,9834,4225,2304,986
Current Portion of Leases
348.4340.98329.53184.41141.5
Current Income Taxes Payable
253.91278.7250.63619.34474.22
Current Unearned Revenue
1,3001,2321,2001,5451,154
Other Current Liabilities
2,5631,5011,2531,9282,063
Total Current Liabilities
36,42437,45333,75833,29829,318
Long-Term Debt
11,86210,44413,50512,1009,049
Long-Term Leases
3,0512,5422,050744.99648.36
Long-Term Unearned Revenue
1,7421,093959.18986.85751.82
Long-Term Deferred Tax Liabilities
3,2603,2453,4453,3633,130
Other Long-Term Liabilities
1,8742,7513,1372,5622,029
Total Liabilities
58,21457,52756,85353,05544,927
Common Stock
2,6702,6712,6722,6722,563
Additional Paid-In Capital
16,37716,59116,85316,99214,041
Retained Earnings
32,07129,54527,50126,17023,858
Treasury Stock
-607.96-234.38-41.93-53.25-
Comprehensive Income & Other
-1,769-1,313-1,300-1,198-1,266
Total Common Equity
48,74247,26145,68544,58239,196
Minority Interest
13,09912,67310,9319,5269,184
Shareholders' Equity
61,84059,93456,61654,10948,380
Total Liabilities & Equity
120,054117,461113,470107,16493,306
Total Debt
36,42736,02135,03530,19125,454
Net Cash (Debt)
-21,069-19,901-19,453-13,021-10,896
Net Cash Per Share
-7.96-7.45-7.29-4.99-4.25
Filing Date Shares Outstanding
2,6402,6572,6722,6722,563
Total Common Shares Outstanding
2,6402,6582,6722,6722,563
Working Capital
-2,604-2,96234.991,9811,118
Book Value Per Share
18.4717.7817.1016.6815.29
Tangible Book Value
23,93321,88821,35121,77419,519
Tangible Book Value Per Share
9.078.237.998.157.62
Land
1,021943.68951.74201.31203.68
Buildings
14,06112,92711,4717,7336,605
Machinery
16,34715,39214,02610,7009,197
Construction In Progress
3,0553,4354,9384,8973,618
Source: S&P Global Market Intelligence. Standard template. Financial Sources.